Name: Dayco Securities
Address: Poddar Point, North Block, th Floor, 113 Park Street, Kolkata, 700 016, IN
Telephone: +91 33 4067 5066

Back To Homepage

As on (07 Dec 2025 | 17:33)

Back To Homepage As on (07 Dec 2025 | 17:33)

Sun Pharmaceutical Industries Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524715

ISIN Demat INE044A01036

Book Value 99.25

NSE Symbol SUNPHARMA

Div & Yield % 0.89

Market Cap (₹ Cr.) 433067.97

P/E 92.66

EPS 19.48

Face Value 1

Chart

News
Sun Pharma launches innovative drug ILUMYA (Tildrakizumab) in India
Sun Pharmaceuticals Industries to conduct board meeting
Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies
Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States
Sun Pharmaceuticals Industries to table results
Sun Pharma updates on US FDA inspection
Board of Sun Pharmaceutical Industries appoints director
Board of Sun Pharmaceuticals Industries recommends final dividend
Sun Pharmaceuticals Industries announces board meeting date
Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II

Corporate Details
Incorporation Year : 1993
Chairman :
Business Group :
Registered Office : Sun Pharmaceutical Industries Ltd Sun Pharma Advanced Res.Centre, Tandalja, Vadodara, Gujarat - 390020, Phone : 91-265-6615500, Fax : 91-265-2354897
E-Mail : secretarial@sunpharma.com
URL : http://www.sunpharma.com